Cancer immunotherapy .net

Information on human tumours pilot studies 2 Mesothelioma

cancerimmunotherapy@yahoo.com

tumour type

Results in brief: 2 patients treated; mesothelioma in 1 Research in progress

2001

Krastev Z, Koltchakov V, Vladov N, Popov D, Milev A, Koten JW, Den Otter W. Cancer Immunol Immunother. 2001 Jun;50(4):226-7. A mesothelioma that is sensitive to locally applied IL-2. Publication Types: Case Reports. Letter

Paper above describing beneficial results for 1 patient with mesothelioma Krastev et al. (2001) Cancer Immunol. Immunother. 50, 226 Paper describing non-beneficial results for 1 patient with mesothelioma and 15 patients with other abdominal cancers Krastev et al. (2005) World J. Gastroenterol. 11, 5525

tumour type

Interleukin-2 (IL-2) Mechanism of IL-2 therapy of cancer Cancers sensitve to IL-2 Surgery and IL-2 Radiotherapy and IL-2 Chemotherapy and IL-2 Experts I want to co-operate (doctors) Frequently Asked Questions (FAQs)

Information for doctors Information for patients I want to support this research or  more information on the EPTI fund supporting this research

Our research is supported by Stichting ter bevordering van het onderzoek in de Experimentele Pathologie en in het bijzonder in de TumourImmunologie. Stichting EPTI, IJselstein, The Netherlands